By rapidly standing up clinical trial sites in underrepresented communities, Walgreens delivered results that outperformed traditional models. In a pivotal Phase 3 obesity and diabetes study, the approach led to 57% Black and Hispanic enrollment, exceptional quality scores, and 100% patient retention at the 90-day visit.
Download now to see how Walgreens applied innovative engagement tactics and delivered best-in-class results.
This case study reveals how Walgreens:
- Launched fully equipped trial sites in less than 3 months
- Reached and enrolled highly representative patient populations
- Delivered retention rates that exceeded expectations in a challenging Phase 3 study
- Introduced new tactics now recognized as best-in-class by the sponsor
Get insights you can apply to:
Accelerate enrollment, improve representation, and strengthen retention in future clinical trials.
Offered Free by: Walgreens
See All Resources from: Walgreens
